Nordic Tech List (NTL): Discover Scandinavian startups and investors
Nordic Tech List uses cookies to improve your experience and so you don't have to see this annoying banner every time you visit the site. By continuing to use the site you accept the use of cookies. More information about cookies
Privacy update: We have provided additional information in our privacy policy to clarify how we process personal data.
OxThera
euro_symbol
Looking for funding: Unknown
arrow_forward
Unknown revenue growth
business
Company
Sweden

OxThera

OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria, and enzymes. Oxabact® holds Orphan Drug designations in Europe and in the US for the treatment of primary hyperoxaluria. CEO is Elisabeth Lindner.

Edit organization
Founded9 June 2005
Organization number5566815667
Number of Employees5
Main office (address)
Sturegatan 56, 114 36 Stockholm, Sweden
Looking for funding?

Funding

Funding Roundschevron_left
No funding rounds added for this organization.
Investors & Shareholderschevron_left
Investmentschevron_left

Connections

Timeline

2018
2005 - Founded

Exit

No exit added
Add exit

The content of this page is partly user generated and not controlled by the Nordic Tech List editorial team, nor is it part of the Nordic Tech List editorial database: Nordictechlist.com. For more info see FAQ.